Sarepta Therapeutics Inc
NASDAQ:SRPT
Sarepta Therapeutics Inc
NASDAQ:SRPT
Price:
16.52
USD
-1.67%
Market Cap:
$1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
US |
|
T
|
Tesla Inc
MIL:TSLA
|
US |
|
S
|
Smart Powerr Corp
NASDAQ:CREG
|
CN |
|
Yamada Holdings Co Ltd
TSE:9831
|
JP |
|
Adobe Inc
NASDAQ:ADBE
|
US |
|
S
|
Symrise AG
XMUN:SY1
|
DE |
|
T
|
Telstra Group Ltd
F:5KB
|
AU |
|
Sterlite Technologies Ltd
NSE:STLTECH
|
IN |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
US |
|
NextNav Inc
NASDAQ:NN
|
US |
|
Post Holdings Inc
NYSE:POST
|
US |
|
STAG Industrial Inc
NYSE:STAG
|
US |
|
Werner Enterprises Inc
NASDAQ:WERN
|
US |
|
T
|
Teck Resources Ltd
TSX:TECK.B
|
CA |
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
Wall St Price Targets
SRPT Price Targets Summary
Sarepta Therapeutics Inc
Sarepta Therapeutics Inc
Wall Street analysts forecast SRPT stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for SRPT is 22.87 USD with a low forecast of 5.05 USD and a high forecast of 39.9 USD.
Lowest Forecast
Price Target
5.05
USD
69% Downside
Average Forecast
Price Target
22.87
USD
38% Upside
Highest Forecast
Price Target
39.9
USD
142% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SRPT's stock price target?
Price Target
22.87
USD
22.87
USD
According to Wall Street analysts, the average 1-year price target for SRPT is 22.87 USD with a low forecast of 5.05 USD and a high forecast of 39.9 USD.
What is the Revenue forecast for Sarepta Therapeutics Inc?
Projected CAGR
-3%
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is -3%.
